Comparing methylation levels assayed in GC-rich regions with current and emerging methods

Area of Science:

• Epigenetics
• Genomics
• Molecular Biology

Background:

• DNA methylation is a crucial epigenetic regulator of gene expression in mammals, primarily occurring at CpG dinucleotides.
• Accurate measurement of DNA methylation, particularly in GC-rich regions like gene promoters, is essential for reliable biological interpretation but remains a challenge.
• Existing methylation detection methods face limitations in accurately quantifying methylation levels in challenging genomic areas.

Purpose of the Study:

• To compare the performance of four distinct DNA methylation detection methods: Enzymatic Methyl-seq (EM-seq), whole genome bisulphite sequencing (WGBS), Infinium arrays (EPIC), and Oxford Nanopore Technologies (ONT) nanopore sequencing.
• To evaluate the accuracy and consistency of these methods in assessing DNA methylation levels across the human genome, with a focus on GC-rich regions.
• To provide recommendations for selecting the optimal methylation analysis technique based on specific research questions and translational requirements.

Main Methods:

• Human DNA samples were analyzed using four different DNA methylation detection technologies: EM-seq, WGBS, EPIC arrays, and ONT nanopore sequencing.
• Methylation levels were quantified and compared across the genome for each method.
• The susceptibility of each method to GC bias was assessed.

Main Results:

• All four methods yielded comparable and consistent DNA methylation readouts across the human genome.
• EM-seq and ONT demonstrated superior technical performance over WGBS, exhibiting less GC bias and improved coverage.
• WGBS offers broad genome-wide interrogation flexibility, while EM-seq requires more laboratory time and ONT presents higher complexity.

Conclusions:

• EM-seq and ONT represent technically advanced alternatives to WGBS for DNA methylation analysis, offering reduced GC bias.
• The choice of methylation detection method depends on balancing technical advantages (coverage, bias reduction) against practical considerations (time, complexity).
• Understanding the strengths and weaknesses of each method is critical for informed selection in diverse scientific and translational applications.